Clinical Trials Browser

Withdrawn × INDUSTRY × Inotuzumab Ozogamicin × Clear all

NCT03628053 2020-07-09

OBERON

Phase 3 Withdrawn

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma